பூகோளம் பயோடெக் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

‘Bangavax’ single-dose vaccine effective against Covid-19: US medical journal The world’s first one-dose mRNA vaccine against the coronavirus (SARS-COV-2) developed by Globe Biotech Limited of Bangladesh has been published in the renowned US medical journal ‘Vaccine’. ‘Bangavax’ is the world’s first effective single-dose vaccine made using mRNA technology that has successfully shown strong protection in human cells and animals against the SARS-Cov-2 virus. Globe Biotech Limited, a Bangladeshi company, has developed this vaccine with its own technology in tandem with world-renowned vaccine developers which also take Bangladesh to a unique height on the world stage. Despite the inherent limitations of working in developing countries like Bangladesh, such as the management of raw materials, adaptation to new technologies, lack of research funds, etc. the vaccine was developed by a smart team of young scientists led by Dr. Nazneen Sultana and Kakon Nag.

Nazneen sultanaGlobe biotechGlobe biotech limited of bangladeshGlobe biotech limitedBiotech limitedநஜ்னீன் சுல்தானாபூகோளம் பயோடெக்பூகோளம் பயோடெக் வரையறுக்கப்பட்டவை ஆஃப் பங்களாதேஷ்பூகோளம் பயோடெக் வரையறுக்கப்பட்டவைபயோடெக் வரையறுக்கப்பட்டவை